136 related articles for article (PubMed ID: 15721587)
1. Crystal structure of a cross-reaction complex between an anti-HIV-1 protease antibody and an HIV-2 protease peptide.
Rezacova P; Brynda J; Lescar J; Fabry M; Horejsi M; Sieglova I; Sedlacek J; Bentley GA
J Struct Biol; 2005 Mar; 149(3):332-7. PubMed ID: 15721587
[TBL] [Abstract][Full Text] [Related]
2. Preliminary crystallographic studies of an anti-HIV-1 protease antibody that inhibits enzyme activity.
Lescar J; Stouracova R; Riottot MM; Chitarra V; Brynda J; Fabry M; Horejsi M; Sedlacek J; Bentley GA
Protein Sci; 1996 May; 5(5):966-8. PubMed ID: 8732768
[TBL] [Abstract][Full Text] [Related]
3. Structural basis of HIV-1 and HIV-2 protease inhibition by a monoclonal antibody.
Rezacova P; Lescar J; Brynda J; Fabry M; Horejsi M; Sedlacek J; Bentley GA
Structure; 2001 Oct; 9(10):887-95. PubMed ID: 11591344
[TBL] [Abstract][Full Text] [Related]
4. Three-dimensional structure of an Fab-peptide complex: structural basis of HIV-1 protease inhibition by a monoclonal antibody.
Lescar J; Stouracova R; Riottot MM; Chitarra V; Brynda J; Fabry M; Horejsi M; Sedlacek J; Bentley GA
J Mol Biol; 1997 Apr; 267(5):1207-22. PubMed ID: 9150407
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of HIV protease by monoclonal antibodies.
Rezacova P; Brynda J; Fabry M; Horejsi M; Stouracova R; Lescar J; Chitarra V; Riottot MM; Sedlacek J; Bentley GA
J Mol Recognit; 2002; 15(5):272-6. PubMed ID: 12447903
[TBL] [Abstract][Full Text] [Related]
6. Anti-HIV proteinase monoclonal antibody F11.2.32 that inhibits enzyme activity.
Stouracova R; Lescar J; Brynda J; Riottot MM; Chitarra V; Fabry M; Horejsi M; Rezacova P; Bentley G; Sedlacek J
Gen Physiol Biophys; 1998 Jun; 17 Suppl 1():6-8. PubMed ID: 9789741
[No Abstract] [Full Text] [Related]
7. Structure of a single-chain Fv fragment of an antibody that inhibits the HIV-1 and HIV-2 proteases.
Lescar J; Brynda J; Fabry M; Horejsi M; Rezacova P; Sedlacek J; Bentley GA
Acta Crystallogr D Biol Crystallogr; 2003 May; 59(Pt 5):955-7. PubMed ID: 12777823
[TBL] [Abstract][Full Text] [Related]
8. Structural studies of HIV-1 protease-inhibiting antibodies.
Lescar J; Stouracova R; Riottot MM; Chitarra V; Brynda J; Fabry M; Horejsi M; Sedlacek J; Bentley GA
Gen Physiol Biophys; 1998 Jun; 17 Suppl 1():3-6. PubMed ID: 9789740
[No Abstract] [Full Text] [Related]
9. Crystal structure of the complex between the F(ab)' fragment of the cross-neutralizing anti-HIV-1 antibody 2F5 and the F(ab) fragment of its anti-idiotypic antibody 3H6.
Bryson S; Julien JP; Isenman DE; Kunert R; Katinger H; Pai EF
J Mol Biol; 2008 Oct; 382(4):910-9. PubMed ID: 18692506
[TBL] [Abstract][Full Text] [Related]
10. Structural studies of human HIV-1 V3 antibodies.
Stanfield RL; Wilson IA
Hum Antibodies; 2005; 14(3-4):73-80. PubMed ID: 16720977
[TBL] [Abstract][Full Text] [Related]
11. Conformational and dynamical basis for cross-reactivity observed between anti HIV-1 protease antibody with protease and an epitope peptide from it.
Badaya A; Sasidhar YU
Int J Biol Macromol; 2018 Oct; 118(Pt B):1696-1707. PubMed ID: 29990556
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of aspartic proteinase from Irpex lacteus in complex with inhibitor pepstatin.
Fujimoto Z; Fujii Y; Kaneko S; Kobayashi H; Mizuno H
J Mol Biol; 2004 Aug; 341(5):1227-35. PubMed ID: 15321718
[TBL] [Abstract][Full Text] [Related]
13. Induced fit in HIV-neutralizing antibody complexes: evidence for alternative conformations of the gp120 V3 loop and the molecular basis for broad neutralization.
Rosen O; Chill J; Sharon M; Kessler N; Mester B; Zolla-Pazner S; Anglister J
Biochemistry; 2005 May; 44(19):7250-8. PubMed ID: 15882063
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of a retroviral protease proves relationship to aspartic protease family.
Miller M; Jaskólski M; Rao JK; Leis J; Wlodawer A
Nature; 1989 Feb; 337(6207):576-9. PubMed ID: 2536902
[TBL] [Abstract][Full Text] [Related]
15. Unexpected novel binding mode of pyrrolidine-based aspartyl protease inhibitors: design, synthesis and crystal structure in complex with HIV protease.
Specker E; Böttcher J; Brass S; Heine A; Lilie H; Schoop A; Müller G; Griebenow N; Klebe G
ChemMedChem; 2006 Jan; 1(1):106-17. PubMed ID: 16892342
[TBL] [Abstract][Full Text] [Related]
16. X-ray structure of HIV-1 protease in situ product complex.
Bihani S; Das A; Prashar V; Ferrer JL; Hosur MV
Proteins; 2009 Feb; 74(3):594-602. PubMed ID: 18704947
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of chimeric antibody C2H7 Fab in complex with a CD20 peptide.
Du J; Wang H; Zhong C; Peng B; Zhang M; Li B; Hou S; Guo Y; Ding J
Mol Immunol; 2008 May; 45(10):2861-8. PubMed ID: 18346788
[TBL] [Abstract][Full Text] [Related]
18. Head-to-tail dimers and interdomain flexibility revealed by the crystal structure of HIV-1 capsid protein (p24) complexed with a monoclonal antibody Fab.
Berthet-Colominas C; Monaco S; Novelli A; Sibaï G; Mallet F; Cusack S
EMBO J; 1999 Mar; 18(5):1124-36. PubMed ID: 10064580
[TBL] [Abstract][Full Text] [Related]
19. Ddi1, a eukaryotic protein with the retroviral protease fold.
Sirkis R; Gerst JE; Fass D
J Mol Biol; 2006 Dec; 364(3):376-87. PubMed ID: 17010377
[TBL] [Abstract][Full Text] [Related]
20. Cross-reactivity studies of an anti-Plasmodium vivax apical membrane antigen 1 monoclonal antibody: binding and structural characterisation.
Igonet S; Vulliez-Le Normand B; Faure G; Riottot MM; Kocken CH; Thomas AW; Bentley GA
J Mol Biol; 2007 Mar; 366(5):1523-37. PubMed ID: 17229439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
